Activist 13D/13G Filings - Medicxi Growth I LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-01-26
4:00 pm
Purchase		13GPHATHOM PHARMACEUTICALS INC CO
PHAT		Medicxi Growth I LP7,464,572
13%		4,980,298increase
(+200.47%)		View
2023-01-31
4:00 pm
Purchase		13GCENTESSA PHARMACEUTICALS PLC S
CNTA		Medicxi Growth I LP19,963,157
21.1%		1,839,265increase
(+10.15%)		View
2023-01-31
4:00 pm
Purchase		13GPHATHOM PHARMACEUTICALS INC CO
PHAT		Medicxi Growth I LP2,484,274
6%		416,413increase
(+20.14%)		View
2022-02-08
08:27 am
Purchase		13GCENTESSA PHARMACEUTICALS PLC S
CNTA		Medicxi Growth I LP18,123,892
20.16%		18,123,892increase
(New Position)		View
2021-11-10
3:21 pm
Purchase		13DAURA BIOSCIENCES INC
AURA		Medicxi Growth I LP3,039,892
10.7%		3,039,892increase
(New Position)		View
2021-02-11
10:27 am
Unchanged		13GOBSEVA SA COM SHS
OBSV		Medicxi Growth I LP1,570,000
2.85%		0
(Unchanged)		View
2021-02-11
08:41 am
Unchanged		13GMERUS N V COM
MRUS		Medicxi Growth I LP1,600,000
4.3%		0
(Unchanged)		View
2020-08-18
4:29 pm
Purchase		13GCHECKMATE PHARMACEUTICALS, INC
CMPI		Medicxi Growth I LP1,501,716
7%		1,501,716increase
(New Position)		View
2020-02-10
12:00 pm
Purchase		13GPHATHOM PHARMACEUTICALS INC CO
PHAT		Medicxi Growth I LP2,067,861
8.4%		2,067,861increase
(New Position)		View
2019-11-14
11:03 am
Purchase		13GMERUS N V COM
MRUS		Medicxi Growth I LP1,600,000
5.5%		1,600,000increase
(New Position)		View